Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences